<html><body><h2>Case: 1305832519626</h2>
<patient name=108778>
78.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">78</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1978-5-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1978-5-2</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">110</td><td width="200">1978-5-1</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1978-6-6</td></tr>
<tr><td width="200">Height</td><td width="200">66</td><td width="200">1978-5-24</td></tr>
<tr><td width="200">Chloride</td><td width="200">100.0</td><td width="200">1978-5-2</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">90</td><td width="200">1978-7-4</td></tr>
<tr><td width="200">BUN</td><td width="200">22</td><td width="200">1978-5-2</td></tr>
<tr><td width="200">BNP</td><td width="200">1,447</td><td width="200">1978-5-1</td></tr>
<tr><td width="200">HGB</td><td width="200">12</td><td width="200">1978-6-6</td></tr>
<tr><td width="200">HCT</td><td width="200">33</td><td width="200">1978-6-6</td></tr>
<tr><td width="200">Sodium</td><td width="200">136</td><td width="200">1978-6-6</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1978-5-1</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.5</td><td width="200">1978-5-2</td></tr>
<tr><td width="200">Weight</td><td width="200">183</td><td width="200">1978-5-24</td></tr>
<tr><td width="200">SGOT</td><td width="200">17</td><td width="200">1978-5-1</td></tr>
<tr><td width="200">Pulse</td><td width="200">100</td><td width="200">1978-7-4</td></tr>
<tr><td width="200">PLT</td><td width="200">297</td><td width="200">1978-5-2</td></tr>
<tr><td width="200">WBC</td><td width="200">13</td><td width="200">1978-5-2</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">141</td><td width="200">1978-7-4</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1978-7-4</td></tr>
<tr><td width="200">SGPT</td><td width="200">23</td><td width="200">1978-5-1</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1978-7-4</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1978-6-5</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1978-5-1</td></tr>
<tr><td width="200">Nephritis_nephrosis_renal sclerosis</td><td width="200"></td><td width="200">1978-6-5</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
</table>
<p><b>Medications:</b> glyburide(0.5) aspirin(81.0) metformin(0.0) simvastatin(5.0) furosemide(10.0) Insulin(7.0) glipizide(0.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">CRI</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(1.5/1978-5-2) && Sex(Female) && Creatinine(1.5/1978-5-2)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">Heart Failure and BP not controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure[presence of heart failure && BP not adequately controlled based on most recent BPTreatment_Diastolic_BP(90/null)]()</td></tr>
<tr><td width="200">Diabetes WITHOUT proteinuria/renal manifestations</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of diabetes mellitus && Absence of diabetic with renal manifestations && Absence of diabetic nephropathy && Absence of diabetic nephrosis && Proteinuria equals trace or above && Absence of ARB]()</td></tr>
<tr><td width="200">DM and BP not controlled</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of DM && BP not adequately controlled based on most recent BPTreatment_Diastolic_BP(90/null)]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(78.0/1970-1-1)]()</td></tr>
<tr><td width="200">No med and (HCTZ: presence of absolute contraindication or bad drug partner)</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">No med and K>=3.5</td>
<td width="200"></td>
<td width="200"> 1st line drug for hypertension[Potassium(4.0/1978-6-6) && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(78.0/1970-1-1)]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1978-06-05</td>
<td width="200"> Nephritis_nephrosis_renal sclerosis()</td></tr>
<tr> <td width="200"></td>
<td width="200">1978-06-05</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1978-05-01</td>
<td width="200"> Heart_Failure()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1978-07-04</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 100 mg/dL(CHD Risk Equivalent)
<p><b>Reached goal?</b> unknown(LDL_Cholesterol(no value))
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Diastolic_BP(90/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>No comment
</ul>
<li>No comment
</ul>
<li>No comment
</ul>
<li>No comment
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>No comment
</ul>
<li>No comment
</ul>
<li>No comment
</ul>
<li>No comment
</ul>
<li>No comment
</ul>
</ul>
</ul>
</body></html>